In Brief: Chattem
This article was originally published in The Tan Sheet
Executive Summary
Chattem: Acquires Herpecin-L cold sore lip balm from Deerfield, Fla.-based Campbell Labs on June 6. Chattem announced on May 24 that a $5.5 mil. purchase of a "small but profitable" oral care line was pending ("The Tan Sheet" June 3, p. 8). Herpecin-L, Campbell's only product, generates "well over" $3 mil. in annual sales, according to Chattem. The product will join Benzodent analgesic cream for denture wearers, acquired from Procter & Gamble in May 1994...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning